Lung Disease News |
Reslizumab Reduces Risk of Severe Asthma Exacerbations
Lung Disease News A total of 953 patients took part in the two double-blind, parallel-group, randomized, placebo-controlled phase 3 trials from 232 health centers around the world. Patients had asthma that has been difficult to control with normal steroid therapy. For … |
View full post on asthma – Google News